Skip to main content
Signal8

Item 9 Labs Corp. (INLB)

Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Item 9 Labs Corp. logo

Item 9 Labs Corp.

OTC:INLBHealthcare
CLOSED
Mkt Cap-
EV-
Float524.14M
O/S701.81M
VOL400 sh
RVOL1.00×
Inst Own-
Net Cash/Sh-
EarningsDec 2 · in 2w
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 524.14M · FMP free float

3.6K
Apr 15 (946d)prev 453.1K▼ 99.2%
1.00
Apr 15 (946d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow INLB shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for INLB: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually